Winning Strategies: How to Create, Grow, and Sustain a Successful Life Sciences Company

14 October 2011 San Diego, CA Past Event

Location

The Hyatt La Jolla
3777 La Jolla Village Drive
San Diego, CA 92122

Contact Information

Delia Dai
ddai@foley.com

Agenda

8:30 a.m. -
Registration and Continental Breakfast

9:15 a.m. - 3:30 p.m. -
Program & Lunch

3:30 p.m. - 5:00 p.m. -
Reception

Today’s biotech market is experiencing a slow but steady rebound.

However, success doesn’t come easy. Excelling in today’s financial and regulatory environment demands not only new approaches to raising and sustaining cash flow and a strong IP and regulatory strategy, but also new models for protecting assets and driving innovation.

You are invited to join Foley & Lardner LLP, PricewaterhouseCoopers, and Berkley Life Sciences for Winning Strategies: How to Create, Grow, and Sustain a Successful Life Sciences Company. During this full-day conference, financial advisors, industry leaders, and legal counsel will provide insight on critical business, regulatory and legal issues while highlighting the advancements of critical technology in the life sciences industry.

Featured Keynote Speaker:  Gregory C. Simon, Senior Vice President, Patient Engagement, Pfizer Inc., and co-founder and board member of FasterCures Foundation.

We are pleased to feature six different panels in two distinct tracks. New speakers are added on a frequent basis, we will update panel information as these confirmations are made.

Track One: Growing Your Life Science Start-Up

  • Lighting the Way: The Alternative Path to Financing
  • New Models for Corporate Transactions in Life Sciences

Track Two: Sustainability for the Growth Stage Life Sciences Company

  • Winning Strategies: Achieving an IPO in Today’s Market
  • From Office to Off-Label: Managing Risk & Protecting Assets
  • New Paradigms for Advancing Personalized Medicine

PricewaterhouseCoopers LLP Logo        Berkley Life Sciences Logo

ShareVault Logo        Personalized Medicine Coalition Logo     

Presentation and Materials

Off-label promotion continues to be a main focus of FDA enforcement action. Current trends point to industry executives also facing personal liability risks when found to be incompliant with FDA guidelines.

Today's life sciences companies are tasked with making sense of the gray areas concerning product promotion and other FDA enforcement priorities. But even before commercializing a product, understanding and identifying risks are key to any life science company. Whether these risks begin in the pre-clinical stage or while the product is commercialized, knowing the potential landminds is important in developing and implementing a risk management plan.

During this session panelists will discuss:

  • Relevant compliance laws and FDA regulations
  • Legal parameters Associated with off-label marketing
  • Collateral consequences of off-label investigations
  • Best practices for reducing the risks

Moderated by Emily Urban, Senior Vice President, Berkley Life Sciences

  • Speaker: Anne Nevard, Life Sciences Risk Management CEO
  • Speaker: Judy Waltz, Partner,  Foley & Lardner LLP
  • Speaker: George M. Ward, Director of Risk Management, Corporate Compliance, Amylin Pharmaceuticals, Inc.
  • Moderated by David Charapp, Foley & Lardner LLP
  • Speaker: Sanjay Shukla,MD, Chief Executive Officer, RxMD
  • Speaker: LenaA. Basile, Ph.D., J.D., President, Chief Executive Officer, Neumedicines
  • Speaker: Randy Berholtz, Executive Vice President, General Counsel and Secretary, Apricus Bio
  • Moderated by Richard Kaufman, Foley & Lardner LLP
  • Speaker: James Chapman, Foley & Lardner LLP
  • Speaker: David M. Sabow, Vice President, Investment Banking. Canaccord Genuity Inc.
  • Speaker: Mark P. Stevenson, President and Chief Operating Officer, Life Technologies
  • Moderated by Antoinette Konski, Foley & Lardner LLP
  • Speaker: Ken Goldman, Global Head, Diagnostics Patents, Novartis Vaccines & Diagnostics, Inc.
  • Speaker: Suneel Ratan, Founder and CEO of Care Architecture
  • Speaker: Anita Chawla, Ph.D., Vice President, Analysis Group
  • Moderated by Vanessa Herbert, Senior Manager, PricewaterhouseCoopers
  • Speaker: Kevin O’Boyle, Senior Vice President and Chief Financial Officer, Advanced BioHealing, Inc.
  • Speaker: Paul Broude, Foley & Lardner LLP
  • Speaker: Bill Smith, Vice President Legal Affairs, General Counsel, Fluidigm Corporation

Winning Strategies: How to Create, Grow, and Sustain a Successful Life Sciences Company

Location

The Hyatt La Jolla
3777 La Jolla Village Drive
San Diego, CA 92122

Contact Information

Delia Dai
ddai@foley.com

Agenda

8:30 a.m. -
Registration and Continental Breakfast

9:15 a.m. - 3:30 p.m. -
Program & Lunch

3:30 p.m. - 5:00 p.m. -
Reception